UNCLASSIFIED
ARCHIVED Skip navigation.PDF Version     To Publications Page     To Home Page

Title:

Lake County High Intensity Drug Trafficking Area Drug Market Analysis 2010

Publication Date: April 2010

Cover image for the Lake County HIDTA Drug Market Analysis 2010.Document ID: 2010-R0813-012

Archived on: September 1, 2011. This document may contain dated information. It remains available to provide access to historical materials.

This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been coordinated with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.

Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.


Contents

Strategic Drug Threat Developments

HIDTA Overview

Drug Threat Overview

Drug Trafficking Organizations

Production

Transportation

Distribution

Drug-Related Crime

Abuse

Illicit Finance

Outlook

Sources


List of Figures

Figure 1. Lake County High Intensity Drug Trafficking Area

List of Tables

Table 1. Individuals Receiving Drug Abuse Treatment Services in Lake County Through the Hoosier Assurance Plan, by Drug, 2005-2009
Table 2. Percentage of Twelfth-Grade Students Reporting Lifetime Drug Use, by Drug, Northwest Region of Indiana, Compared With Statewide Data, 2009


Strategic Drug Threat Developments

The distribution and abuse of crack cocaine and heroin are the primary drug threats to the Lake County High Intensity Drug Trafficking Area (HIDTA) region. The following are significant strategic drug threat developments in the region:

To Top      To Contents


Addresses

National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622

Tel. (814) 532-4601
FAX (814) 532-4690
E-mail NDIC.Contacts@usdoj.gov

 

Office of Policy and Interagency Affairs
U.S. Department of Justice
Robert F. Kennedy Building, Room 3341
950 Pennsylvania Avenue, NW
Washington, D.C. 20530-2000

Telephone: (202) 532-4040
FAX (202) 514-4252

Web Addresses

ADNET:  http://ndicosa.adnet.sgov.gov
DOJ:  http://www.justice.gov/archive/ndic/
LEO:  https://www.leo.gov/http/leowcs.leopriv.gov/lesig/archive/ndic/index.htm
RISS:  ndic.riss.net


Footnote

a. Opioid pain relievers include codeine, fentanyl (Duragesic, Actiq), hydromorphone (Dilaudid), meperidine (Demerol), morphine (MS Contin), oxycodone (OxyContin, Roxicodone), methadone (Dolophine), and hydrocodone combinations (Vicodin, Lortab, and Lorcet).


To Top     To Contents     To Next Page

To Publications Page     To Home Page

UNCLASSIFIED


End of page.